fluspirilene has been researched along with Remission, Spontaneous in 1 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| König, L | 1 |
| Lange, E | 1 |
1 other study available for fluspirilene and Remission, Spontaneous
| Article | Year |
|---|---|
[Significance and advantages of Orap in the ambulatory care of schizophrenic psychoses].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Cyclothymic Disorder; Depression; Depressive Disorder, Maj | 1976 |